Funded Tech Companies

Vividion Therapeutics

Wondering who bought Vividion Therapeutics? Vividion Therapeutics was purchased by Bayer AG.

Company Overview

Contact Information

Company Background Information

Overview

Vividion Therapeutics is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide ligand and target discovery.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

8/5/2021

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Hatfield

        

Chief Financial Officer

Patty Allen

        

Chief Scientific Officer

Robert Abraham

        

Company Investors

• SoftBank Group
• BVF Partners
• BlackRock
• Boxer Capital (Aaron Davis)
• venBio
• Nextech Invest (Jakob Loven)
• Mubadala
• Arch Venture Partners (Kristina Burow)
• Logos Capital (Graham Walmsley)
• Versant Ventures (Tom Woiwode)
• RA Capital
• Casdin Capital
• Acuta Capital
• Driehaus Capital Management
• T. Rowe Price
• Woodline Partners
• Surveyor Capital
• Celgene (Rupert Vessey)
• Alexandria Venture Investments
• Altitude Life Science Ventures
• Mirae Asset Venture Investment
• Trinitas Capital
• Cardinal Partners (John Clarke)

Browse more funded tech companies:

VividCortex | Vividly

Share this article

About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary